Scientific Technical Account Executive
Cadence Design Systems
Cologne, Germany
Nurturing partnerships and digital R&D to drive innovation in early-stage assets in Pharma R&D for novel target explorations and novel hits compounds.
With 10 years of experience as a drug discovery scientist and 7 years of success in sales and business development, I bring an unmatched drive to nurture partnerships and digitization of R&D.
I am responsible for driving Life Science segment of European Business of Cadence Design Systems (#CDNS), world leader in Chip design. Our Cloud-Native Orion® Molecular Design Platform, built by OpenEye, delivers ubiquity and scalability for generating early-stage pharmaceutical R&D assets globally. In between buy or build, we provide both solutions for small molecule drug discovery and novel target explorations.
Project cooperation
Insilico Cryptic Pocket Detection and ligandability assessment
Drug the undruggable proteins by discovering cryptic or allosteric pockets in a novel protein target and AI-Ligandability model.
Expertise
Accelerate drug discovery with OpenEye software
From hit generation to lead optimization and finding cryptic pockets on novel protein targets, OpenEye provides Cloud-native SaaS.